A live webcast of the presentation will be available on the investor section of the Anaptys website at A replay of the webcast will be available for at least 30 days following the event Anaptys is a ...
A group of 18 colorectal cancer patients experienced complete remission after taking the experimental drug dostarlimab for ...
Imsidolimab inhibits the function of the IL-36R, compensating for the deficiency of the endogenous IL-36 regulator in patients with GPP. Imsidolimab has successfully concluded its development program ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback